Literature DB >> 1366776

Rattlesnake and scorpion antivenoms from the egg yolks of immunized hens.

B S Thalley1, S B Carroll.   

Abstract

Antivenoms used to treat poisonous bites and stings are usually derived from horse sera. Consequently, they contain horse immunoglobulins, which frequently cause complement mediated side effects, and other proteins that can cause serum sickness and, occasionally, anaphylactic shock. Here we describe a new, avian source of antivenoms that precludes these complications, and an efficient and gentle means for preparing antivenoms composed solely of venom-specific antibodies. We demonstrate that antivenoms purified from the egg yolks of laying hens immunized with Crotalus atrox rattlesnake venom and Leiurus quinquestriatus hebraeus scorpion venom neutralize the lethal effects of these venoms in vivo. Antivenoms purified from chicken eggs may be pharmaceutically safer and more economical to produce than current horse antivenoms.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1366776     DOI: 10.1038/nbt1090-934

Source DB:  PubMed          Journal:  Biotechnology (N Y)        ISSN: 0733-222X


  9 in total

Review 1.  Pharmacokinetic-pharmacodynamic relationships of immunoglobulin therapy for envenomation.

Authors:  José María Gutiérrez; Guillermo León; Bruno Lomonte
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

2.  Antibodies to recombinant Clostridium difficile toxins A and B are an effective treatment and prevent relapse of C. difficile-associated disease in a hamster model of infection.

Authors:  J A Kink; J A Williams
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

3.  Study on development of Vipera lebetina snake anti-venom in chicken egg yolk for passive immunization.

Authors:  Hossein Zolfagharian; Naser Mohammadpour Dounighi
Journal:  Hum Vaccin Immunother       Date:  2015-02-20       Impact factor: 3.452

4.  Oral passive immunization against dental caries in rats by use of hen egg yolk antibodies specific for cell-associated glucosyltransferase of Streptococcus mutans.

Authors:  S Hamada; T Horikoshi; T Minami; S Kawabata; J Hiraoka; T Fujiwara; T Ooshima
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

5.  Confronting the neglected problem of snake bite envenoming: the need for a global partnership.

Authors:  José María Gutiérrez; R David G Theakston; David A Warrell
Journal:  PLoS Med       Date:  2006-06       Impact factor: 11.069

6.  Antiviral Biologic Produced in DNA Vaccine/Goose Platform Protects Hamsters Against Hantavirus Pulmonary Syndrome When Administered Post-exposure.

Authors:  Nicole Haese; Rebecca L Brocato; Thomas Henderson; Matthew L Nilles; Steve A Kwilas; Matthew D Josleyn; Christopher D Hammerbeck; James Schiltz; Michael Royals; John Ballantyne; Jay W Hooper; David S Bradley
Journal:  PLoS Negl Trop Dis       Date:  2015-06-05

Review 7.  Serotherapy against Voltage-Gated Sodium Channel-Targeting αToxins from Androctonus Scorpion Venom.

Authors:  Marie-France Martin-Eauclaire; Sonia Adi-Bessalem; Djelila Hammoudi-Triki; Fatima Laraba-Djebari; Pierre E Bougis
Journal:  Toxins (Basel)       Date:  2019-01-23       Impact factor: 4.546

Review 8.  Antibodies: an alternative for antibiotics?

Authors:  L R Berghman; D Abi-Ghanem; S D Waghela; S C Ricke
Journal:  Poult Sci       Date:  2005-04       Impact factor: 3.352

Review 9.  IgY: a promising antibody for use in immunodiagnostic and in immunotherapy.

Authors:  Wilmar Dias da Silva; Denise V Tambourgi
Journal:  Vet Immunol Immunopathol       Date:  2010-01-07       Impact factor: 2.046

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.